Interference of the CD30-CD30L pathway reduces atherosclerosis development.
Foks AC, Bot I, Frodermann V, de Jager SC, Ter Borg M, van Santbrink PJ, Yagita H, Kuiper J, van Puijvelde GH.
Foks AC, et al. Among authors: kuiper j.
Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):2862-8. doi: 10.1161/ATVBAHA.112.300509. Epub 2012 Oct 18.
Arterioscler Thromb Vasc Biol. 2012.
PMID: 23087358